Pharma & Healthcare
Global NAD+ Intravenous Therapy Market Research Report 2026
- Feb 24, 26
- ID: 717771
- Pages: 124
- Figures: 124
- Views: 2
This report delivers a comprehensive overview of the global NAD+ Intravenous Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding NAD+ Intravenous Therapy. The NAD+ Intravenous Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global NAD+ Intravenous Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist NAD+ Intravenous Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
The Wellness Lab
Conciergemdla
Azivmedics
Reset IV
Thedripclub
Toronto Functional Medicine Centre
Mobileivmedics
Rocky Mountain Ivmedics
Seaside Skin Care
Premiumhealth
Effect Doctors
Nadclinic
Hydrate IV Bar
LIVV Natural
BioReset Medical
IV Boost UK
Segment by Type
NAD+ Mixed Vitamin Injections
Pure NAD+ Injection
Segment by Application
Clinic
Hospital
Residential
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for NAD+ Intravenous Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global NAD+ Intravenous Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist NAD+ Intravenous Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
The Wellness Lab
Conciergemdla
Azivmedics
Reset IV
Thedripclub
Toronto Functional Medicine Centre
Mobileivmedics
Rocky Mountain Ivmedics
Seaside Skin Care
Premiumhealth
Effect Doctors
Nadclinic
Hydrate IV Bar
LIVV Natural
BioReset Medical
IV Boost UK
Segment by Type
NAD+ Mixed Vitamin Injections
Pure NAD+ Injection
Segment by Application
Clinic
Hospital
Residential
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for NAD+ Intravenous Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NAD+ Intravenous Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 NAD+ Mixed Vitamin Injections
1.2.3 Pure NAD+ Injection
1.3 Market by Application
1.3.1 Global NAD+ Intravenous Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Residential
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NAD+ Intravenous Therapy Market Perspective (2021–2032)
2.2 Global NAD+ Intravenous Therapy Growth Trends by Region
2.2.1 Global NAD+ Intravenous Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 NAD+ Intravenous Therapy Historic Market Size by Region (2021–2026)
2.2.3 NAD+ Intravenous Therapy Forecasted Market Size by Region (2027–2032)
2.3 NAD+ Intravenous Therapy Market Dynamics
2.3.1 NAD+ Intravenous Therapy Industry Trends
2.3.2 NAD+ Intravenous Therapy Market Drivers
2.3.3 NAD+ Intravenous Therapy Market Challenges
2.3.4 NAD+ Intravenous Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NAD+ Intravenous Therapy Players by Revenue
3.1.1 Global Top NAD+ Intravenous Therapy Players by Revenue (2021–2026)
3.1.2 Global NAD+ Intravenous Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top NAD+ Intravenous Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by NAD+ Intravenous Therapy Revenue
3.4 Global NAD+ Intravenous Therapy Market Concentration Ratio
3.4.1 Global NAD+ Intravenous Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NAD+ Intravenous Therapy Revenue in 2025
3.5 Global Key Players of NAD+ Intravenous Therapy Head Offices and Areas Served
3.6 Global Key Players of NAD+ Intravenous Therapy, Products and Applications
3.7 Global Key Players of NAD+ Intravenous Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 NAD+ Intravenous Therapy Breakdown Data by Type
4.1 Global NAD+ Intravenous Therapy Historic Market Size by Type (2021–2026)
4.2 Global NAD+ Intravenous Therapy Forecasted Market Size by Type (2027–2032)
5 NAD+ Intravenous Therapy Breakdown Data by Application
5.1 Global NAD+ Intravenous Therapy Historic Market Size by Application (2021–2026)
5.2 Global NAD+ Intravenous Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America NAD+ Intravenous Therapy Market Size (2021–2032)
6.2 North America NAD+ Intravenous Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America NAD+ Intravenous Therapy Market Size by Country (2021–2026)
6.4 North America NAD+ Intravenous Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NAD+ Intravenous Therapy Market Size (2021–2032)
7.2 Europe NAD+ Intravenous Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe NAD+ Intravenous Therapy Market Size by Country (2021–2026)
7.4 Europe NAD+ Intravenous Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific NAD+ Intravenous Therapy Market Size (2021–2032)
8.2 Asia-Pacific NAD+ Intravenous Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific NAD+ Intravenous Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific NAD+ Intravenous Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America NAD+ Intravenous Therapy Market Size (2021–2032)
9.2 Latin America NAD+ Intravenous Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America NAD+ Intravenous Therapy Market Size by Country (2021–2026)
9.4 Latin America NAD+ Intravenous Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NAD+ Intravenous Therapy Market Size (2021–2032)
10.2 Middle East & Africa NAD+ Intravenous Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa NAD+ Intravenous Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa NAD+ Intravenous Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 The Wellness Lab
11.1.1 The Wellness Lab Company Details
11.1.2 The Wellness Lab Business Overview
11.1.3 The Wellness Lab NAD+ Intravenous Therapy Introduction
11.1.4 The Wellness Lab Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.1.5 The Wellness Lab Recent Development
11.2 Conciergemdla
11.2.1 Conciergemdla Company Details
11.2.2 Conciergemdla Business Overview
11.2.3 Conciergemdla NAD+ Intravenous Therapy Introduction
11.2.4 Conciergemdla Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.2.5 Conciergemdla Recent Development
11.3 Azivmedics
11.3.1 Azivmedics Company Details
11.3.2 Azivmedics Business Overview
11.3.3 Azivmedics NAD+ Intravenous Therapy Introduction
11.3.4 Azivmedics Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.3.5 Azivmedics Recent Development
11.4 Reset IV
11.4.1 Reset IV Company Details
11.4.2 Reset IV Business Overview
11.4.3 Reset IV NAD+ Intravenous Therapy Introduction
11.4.4 Reset IV Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.4.5 Reset IV Recent Development
11.5 Thedripclub
11.5.1 Thedripclub Company Details
11.5.2 Thedripclub Business Overview
11.5.3 Thedripclub NAD+ Intravenous Therapy Introduction
11.5.4 Thedripclub Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.5.5 Thedripclub Recent Development
11.6 Toronto Functional Medicine Centre
11.6.1 Toronto Functional Medicine Centre Company Details
11.6.2 Toronto Functional Medicine Centre Business Overview
11.6.3 Toronto Functional Medicine Centre NAD+ Intravenous Therapy Introduction
11.6.4 Toronto Functional Medicine Centre Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.6.5 Toronto Functional Medicine Centre Recent Development
11.7 Mobileivmedics
11.7.1 Mobileivmedics Company Details
11.7.2 Mobileivmedics Business Overview
11.7.3 Mobileivmedics NAD+ Intravenous Therapy Introduction
11.7.4 Mobileivmedics Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.7.5 Mobileivmedics Recent Development
11.8 Rocky Mountain Ivmedics
11.8.1 Rocky Mountain Ivmedics Company Details
11.8.2 Rocky Mountain Ivmedics Business Overview
11.8.3 Rocky Mountain Ivmedics NAD+ Intravenous Therapy Introduction
11.8.4 Rocky Mountain Ivmedics Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.8.5 Rocky Mountain Ivmedics Recent Development
11.9 Seaside Skin Care
11.9.1 Seaside Skin Care Company Details
11.9.2 Seaside Skin Care Business Overview
11.9.3 Seaside Skin Care NAD+ Intravenous Therapy Introduction
11.9.4 Seaside Skin Care Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.9.5 Seaside Skin Care Recent Development
11.10 Premiumhealth
11.10.1 Premiumhealth Company Details
11.10.2 Premiumhealth Business Overview
11.10.3 Premiumhealth NAD+ Intravenous Therapy Introduction
11.10.4 Premiumhealth Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.10.5 Premiumhealth Recent Development
11.11 Effect Doctors
11.11.1 Effect Doctors Company Details
11.11.2 Effect Doctors Business Overview
11.11.3 Effect Doctors NAD+ Intravenous Therapy Introduction
11.11.4 Effect Doctors Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.11.5 Effect Doctors Recent Development
11.12 Nadclinic
11.12.1 Nadclinic Company Details
11.12.2 Nadclinic Business Overview
11.12.3 Nadclinic NAD+ Intravenous Therapy Introduction
11.12.4 Nadclinic Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.12.5 Nadclinic Recent Development
11.13 Hydrate IV Bar
11.13.1 Hydrate IV Bar Company Details
11.13.2 Hydrate IV Bar Business Overview
11.13.3 Hydrate IV Bar NAD+ Intravenous Therapy Introduction
11.13.4 Hydrate IV Bar Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.13.5 Hydrate IV Bar Recent Development
11.14 LIVV Natural
11.14.1 LIVV Natural Company Details
11.14.2 LIVV Natural Business Overview
11.14.3 LIVV Natural NAD+ Intravenous Therapy Introduction
11.14.4 LIVV Natural Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.14.5 LIVV Natural Recent Development
11.15 BioReset Medical
11.15.1 BioReset Medical Company Details
11.15.2 BioReset Medical Business Overview
11.15.3 BioReset Medical NAD+ Intravenous Therapy Introduction
11.15.4 BioReset Medical Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.15.5 BioReset Medical Recent Development
11.16 IV Boost UK
11.16.1 IV Boost UK Company Details
11.16.2 IV Boost UK Business Overview
11.16.3 IV Boost UK NAD+ Intravenous Therapy Introduction
11.16.4 IV Boost UK Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.16.5 IV Boost UK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NAD+ Intravenous Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 NAD+ Mixed Vitamin Injections
1.2.3 Pure NAD+ Injection
1.3 Market by Application
1.3.1 Global NAD+ Intravenous Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Residential
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NAD+ Intravenous Therapy Market Perspective (2021–2032)
2.2 Global NAD+ Intravenous Therapy Growth Trends by Region
2.2.1 Global NAD+ Intravenous Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 NAD+ Intravenous Therapy Historic Market Size by Region (2021–2026)
2.2.3 NAD+ Intravenous Therapy Forecasted Market Size by Region (2027–2032)
2.3 NAD+ Intravenous Therapy Market Dynamics
2.3.1 NAD+ Intravenous Therapy Industry Trends
2.3.2 NAD+ Intravenous Therapy Market Drivers
2.3.3 NAD+ Intravenous Therapy Market Challenges
2.3.4 NAD+ Intravenous Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NAD+ Intravenous Therapy Players by Revenue
3.1.1 Global Top NAD+ Intravenous Therapy Players by Revenue (2021–2026)
3.1.2 Global NAD+ Intravenous Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top NAD+ Intravenous Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by NAD+ Intravenous Therapy Revenue
3.4 Global NAD+ Intravenous Therapy Market Concentration Ratio
3.4.1 Global NAD+ Intravenous Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NAD+ Intravenous Therapy Revenue in 2025
3.5 Global Key Players of NAD+ Intravenous Therapy Head Offices and Areas Served
3.6 Global Key Players of NAD+ Intravenous Therapy, Products and Applications
3.7 Global Key Players of NAD+ Intravenous Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 NAD+ Intravenous Therapy Breakdown Data by Type
4.1 Global NAD+ Intravenous Therapy Historic Market Size by Type (2021–2026)
4.2 Global NAD+ Intravenous Therapy Forecasted Market Size by Type (2027–2032)
5 NAD+ Intravenous Therapy Breakdown Data by Application
5.1 Global NAD+ Intravenous Therapy Historic Market Size by Application (2021–2026)
5.2 Global NAD+ Intravenous Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America NAD+ Intravenous Therapy Market Size (2021–2032)
6.2 North America NAD+ Intravenous Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America NAD+ Intravenous Therapy Market Size by Country (2021–2026)
6.4 North America NAD+ Intravenous Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NAD+ Intravenous Therapy Market Size (2021–2032)
7.2 Europe NAD+ Intravenous Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe NAD+ Intravenous Therapy Market Size by Country (2021–2026)
7.4 Europe NAD+ Intravenous Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific NAD+ Intravenous Therapy Market Size (2021–2032)
8.2 Asia-Pacific NAD+ Intravenous Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific NAD+ Intravenous Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific NAD+ Intravenous Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America NAD+ Intravenous Therapy Market Size (2021–2032)
9.2 Latin America NAD+ Intravenous Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America NAD+ Intravenous Therapy Market Size by Country (2021–2026)
9.4 Latin America NAD+ Intravenous Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NAD+ Intravenous Therapy Market Size (2021–2032)
10.2 Middle East & Africa NAD+ Intravenous Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa NAD+ Intravenous Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa NAD+ Intravenous Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 The Wellness Lab
11.1.1 The Wellness Lab Company Details
11.1.2 The Wellness Lab Business Overview
11.1.3 The Wellness Lab NAD+ Intravenous Therapy Introduction
11.1.4 The Wellness Lab Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.1.5 The Wellness Lab Recent Development
11.2 Conciergemdla
11.2.1 Conciergemdla Company Details
11.2.2 Conciergemdla Business Overview
11.2.3 Conciergemdla NAD+ Intravenous Therapy Introduction
11.2.4 Conciergemdla Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.2.5 Conciergemdla Recent Development
11.3 Azivmedics
11.3.1 Azivmedics Company Details
11.3.2 Azivmedics Business Overview
11.3.3 Azivmedics NAD+ Intravenous Therapy Introduction
11.3.4 Azivmedics Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.3.5 Azivmedics Recent Development
11.4 Reset IV
11.4.1 Reset IV Company Details
11.4.2 Reset IV Business Overview
11.4.3 Reset IV NAD+ Intravenous Therapy Introduction
11.4.4 Reset IV Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.4.5 Reset IV Recent Development
11.5 Thedripclub
11.5.1 Thedripclub Company Details
11.5.2 Thedripclub Business Overview
11.5.3 Thedripclub NAD+ Intravenous Therapy Introduction
11.5.4 Thedripclub Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.5.5 Thedripclub Recent Development
11.6 Toronto Functional Medicine Centre
11.6.1 Toronto Functional Medicine Centre Company Details
11.6.2 Toronto Functional Medicine Centre Business Overview
11.6.3 Toronto Functional Medicine Centre NAD+ Intravenous Therapy Introduction
11.6.4 Toronto Functional Medicine Centre Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.6.5 Toronto Functional Medicine Centre Recent Development
11.7 Mobileivmedics
11.7.1 Mobileivmedics Company Details
11.7.2 Mobileivmedics Business Overview
11.7.3 Mobileivmedics NAD+ Intravenous Therapy Introduction
11.7.4 Mobileivmedics Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.7.5 Mobileivmedics Recent Development
11.8 Rocky Mountain Ivmedics
11.8.1 Rocky Mountain Ivmedics Company Details
11.8.2 Rocky Mountain Ivmedics Business Overview
11.8.3 Rocky Mountain Ivmedics NAD+ Intravenous Therapy Introduction
11.8.4 Rocky Mountain Ivmedics Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.8.5 Rocky Mountain Ivmedics Recent Development
11.9 Seaside Skin Care
11.9.1 Seaside Skin Care Company Details
11.9.2 Seaside Skin Care Business Overview
11.9.3 Seaside Skin Care NAD+ Intravenous Therapy Introduction
11.9.4 Seaside Skin Care Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.9.5 Seaside Skin Care Recent Development
11.10 Premiumhealth
11.10.1 Premiumhealth Company Details
11.10.2 Premiumhealth Business Overview
11.10.3 Premiumhealth NAD+ Intravenous Therapy Introduction
11.10.4 Premiumhealth Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.10.5 Premiumhealth Recent Development
11.11 Effect Doctors
11.11.1 Effect Doctors Company Details
11.11.2 Effect Doctors Business Overview
11.11.3 Effect Doctors NAD+ Intravenous Therapy Introduction
11.11.4 Effect Doctors Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.11.5 Effect Doctors Recent Development
11.12 Nadclinic
11.12.1 Nadclinic Company Details
11.12.2 Nadclinic Business Overview
11.12.3 Nadclinic NAD+ Intravenous Therapy Introduction
11.12.4 Nadclinic Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.12.5 Nadclinic Recent Development
11.13 Hydrate IV Bar
11.13.1 Hydrate IV Bar Company Details
11.13.2 Hydrate IV Bar Business Overview
11.13.3 Hydrate IV Bar NAD+ Intravenous Therapy Introduction
11.13.4 Hydrate IV Bar Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.13.5 Hydrate IV Bar Recent Development
11.14 LIVV Natural
11.14.1 LIVV Natural Company Details
11.14.2 LIVV Natural Business Overview
11.14.3 LIVV Natural NAD+ Intravenous Therapy Introduction
11.14.4 LIVV Natural Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.14.5 LIVV Natural Recent Development
11.15 BioReset Medical
11.15.1 BioReset Medical Company Details
11.15.2 BioReset Medical Business Overview
11.15.3 BioReset Medical NAD+ Intravenous Therapy Introduction
11.15.4 BioReset Medical Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.15.5 BioReset Medical Recent Development
11.16 IV Boost UK
11.16.1 IV Boost UK Company Details
11.16.2 IV Boost UK Business Overview
11.16.3 IV Boost UK NAD+ Intravenous Therapy Introduction
11.16.4 IV Boost UK Revenue in NAD+ Intravenous Therapy Business (2021–2026)
11.16.5 IV Boost UK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global NAD+ Intravenous Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of NAD+ Mixed Vitamin Injections
Table 3. Key Players of Pure NAD+ Injection
Table 4. Global NAD+ Intravenous Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global NAD+ Intravenous Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global NAD+ Intravenous Therapy Market Size by Region (US$ Million), 2021–2026
Table 7. Global NAD+ Intravenous Therapy Market Share by Region (2021–2026)
Table 8. Global NAD+ Intravenous Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global NAD+ Intravenous Therapy Market Share by Region (2027–2032)
Table 10. NAD+ Intravenous Therapy Market Trends
Table 11. NAD+ Intravenous Therapy Market Drivers
Table 12. NAD+ Intravenous Therapy Market Challenges
Table 13. NAD+ Intravenous Therapy Market Restraints
Table 14. Global NAD+ Intravenous Therapy Revenue by Players (US$ Million), 2021–2026
Table 15. Global NAD+ Intravenous Therapy Market Share by Players (2021–2026)
Table 16. Global Top NAD+ Intravenous Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on NAD+ Intravenous Therapy Revenue, 2025
Table 17. Ranking of Global Top NAD+ Intravenous Therapy Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by NAD+ Intravenous Therapy Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of NAD+ Intravenous Therapy, Headquarters and Area Served
Table 20. Global Key Players of NAD+ Intravenous Therapy, Products and Applications
Table 21. Global Key Players of NAD+ Intravenous Therapy, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global NAD+ Intravenous Therapy Market Size by Type (US$ Million), 2021–2026
Table 24. Global NAD+ Intravenous Therapy Revenue Market Share by Type (2021–2026)
Table 25. Global NAD+ Intravenous Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global NAD+ Intravenous Therapy Revenue Market Share by Type (2027–2032)
Table 27. Global NAD+ Intravenous Therapy Market Size by Application (US$ Million), 2021–2026
Table 28. Global NAD+ Intravenous Therapy Revenue Market Share by Application (2021–2026)
Table 29. Global NAD+ Intravenous Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global NAD+ Intravenous Therapy Revenue Market Share by Application (2027–2032)
Table 31. North America NAD+ Intravenous Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America NAD+ Intravenous Therapy Market Size by Country (US$ Million), 2021–2026
Table 33. North America NAD+ Intravenous Therapy Market Size by Country (US$ Million), 2027–2032
Table 34. Europe NAD+ Intravenous Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe NAD+ Intravenous Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. Europe NAD+ Intravenous Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific NAD+ Intravenous Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific NAD+ Intravenous Therapy Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific NAD+ Intravenous Therapy Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America NAD+ Intravenous Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America NAD+ Intravenous Therapy Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America NAD+ Intravenous Therapy Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa NAD+ Intravenous Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa NAD+ Intravenous Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa NAD+ Intravenous Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. The Wellness Lab Company Details
Table 47. The Wellness Lab Business Overview
Table 48. The Wellness Lab NAD+ Intravenous Therapy Product
Table 49. The Wellness Lab Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 50. The Wellness Lab Recent Development
Table 51. Conciergemdla Company Details
Table 52. Conciergemdla Business Overview
Table 53. Conciergemdla NAD+ Intravenous Therapy Product
Table 54. Conciergemdla Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 55. Conciergemdla Recent Development
Table 56. Azivmedics Company Details
Table 57. Azivmedics Business Overview
Table 58. Azivmedics NAD+ Intravenous Therapy Product
Table 59. Azivmedics Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 60. Azivmedics Recent Development
Table 61. Reset IV Company Details
Table 62. Reset IV Business Overview
Table 63. Reset IV NAD+ Intravenous Therapy Product
Table 64. Reset IV Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 65. Reset IV Recent Development
Table 66. Thedripclub Company Details
Table 67. Thedripclub Business Overview
Table 68. Thedripclub NAD+ Intravenous Therapy Product
Table 69. Thedripclub Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 70. Thedripclub Recent Development
Table 71. Toronto Functional Medicine Centre Company Details
Table 72. Toronto Functional Medicine Centre Business Overview
Table 73. Toronto Functional Medicine Centre NAD+ Intravenous Therapy Product
Table 74. Toronto Functional Medicine Centre Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 75. Toronto Functional Medicine Centre Recent Development
Table 76. Mobileivmedics Company Details
Table 77. Mobileivmedics Business Overview
Table 78. Mobileivmedics NAD+ Intravenous Therapy Product
Table 79. Mobileivmedics Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 80. Mobileivmedics Recent Development
Table 81. Rocky Mountain Ivmedics Company Details
Table 82. Rocky Mountain Ivmedics Business Overview
Table 83. Rocky Mountain Ivmedics NAD+ Intravenous Therapy Product
Table 84. Rocky Mountain Ivmedics Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 85. Rocky Mountain Ivmedics Recent Development
Table 86. Seaside Skin Care Company Details
Table 87. Seaside Skin Care Business Overview
Table 88. Seaside Skin Care NAD+ Intravenous Therapy Product
Table 89. Seaside Skin Care Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 90. Seaside Skin Care Recent Development
Table 91. Premiumhealth Company Details
Table 92. Premiumhealth Business Overview
Table 93. Premiumhealth NAD+ Intravenous Therapy Product
Table 94. Premiumhealth Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 95. Premiumhealth Recent Development
Table 96. Effect Doctors Company Details
Table 97. Effect Doctors Business Overview
Table 98. Effect Doctors NAD+ Intravenous Therapy Product
Table 99. Effect Doctors Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 100. Effect Doctors Recent Development
Table 101. Nadclinic Company Details
Table 102. Nadclinic Business Overview
Table 103. Nadclinic NAD+ Intravenous Therapy Product
Table 104. Nadclinic Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 105. Nadclinic Recent Development
Table 106. Hydrate IV Bar Company Details
Table 107. Hydrate IV Bar Business Overview
Table 108. Hydrate IV Bar NAD+ Intravenous Therapy Product
Table 109. Hydrate IV Bar Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 110. Hydrate IV Bar Recent Development
Table 111. LIVV Natural Company Details
Table 112. LIVV Natural Business Overview
Table 113. LIVV Natural NAD+ Intravenous Therapy Product
Table 114. LIVV Natural Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 115. LIVV Natural Recent Development
Table 116. BioReset Medical Company Details
Table 117. BioReset Medical Business Overview
Table 118. BioReset Medical NAD+ Intravenous Therapy Product
Table 119. BioReset Medical Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 120. BioReset Medical Recent Development
Table 121. IV Boost UK Company Details
Table 122. IV Boost UK Business Overview
Table 123. IV Boost UK NAD+ Intravenous Therapy Product
Table 124. IV Boost UK Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 125. IV Boost UK Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. NAD+ Intravenous Therapy Picture
Figure 2. Global NAD+ Intravenous Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global NAD+ Intravenous Therapy Market Share by Type: 2025 vs 2032
Figure 4. NAD+ Mixed Vitamin Injections Features
Figure 5. Pure NAD+ Injection Features
Figure 6. Global NAD+ Intravenous Therapy Market Size by Application (US$ Million), 2021–2032
Figure 7. Global NAD+ Intravenous Therapy Market Share by Application: 2025 vs 2032
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Residential Case Studies
Figure 11. NAD+ Intravenous Therapy Report Years Considered
Figure 12. Global NAD+ Intravenous Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global NAD+ Intravenous Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global NAD+ Intravenous Therapy Market Share by Region: 2025 vs 2032
Figure 15. Global NAD+ Intravenous Therapy Market Share by Players in 2025
Figure 16. Global NAD+ Intravenous Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by NAD+ Intravenous Therapy Revenue in 2025
Figure 18. North America NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America NAD+ Intravenous Therapy Market Share by Country (2021–2032)
Figure 20. United States NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe NAD+ Intravenous Therapy Market Share by Country (2021–2032)
Figure 24. Germany NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific NAD+ Intravenous Therapy Market Share by Region (2021–2032)
Figure 32. China NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America NAD+ Intravenous Therapy Market Share by Country (2021–2032)
Figure 40. Mexico NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa NAD+ Intravenous Therapy Market Share by Country (2021–2032)
Figure 44. Israel NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. The Wellness Lab Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 48. Conciergemdla Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 49. Azivmedics Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 50. Reset IV Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 51. Thedripclub Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 52. Toronto Functional Medicine Centre Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 53. Mobileivmedics Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 54. Rocky Mountain Ivmedics Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 55. Seaside Skin Care Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 56. Premiumhealth Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 57. Effect Doctors Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 58. Nadclinic Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 59. Hydrate IV Bar Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 60. LIVV Natural Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 61. BioReset Medical Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 62. IV Boost UK Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global NAD+ Intravenous Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of NAD+ Mixed Vitamin Injections
Table 3. Key Players of Pure NAD+ Injection
Table 4. Global NAD+ Intravenous Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global NAD+ Intravenous Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global NAD+ Intravenous Therapy Market Size by Region (US$ Million), 2021–2026
Table 7. Global NAD+ Intravenous Therapy Market Share by Region (2021–2026)
Table 8. Global NAD+ Intravenous Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global NAD+ Intravenous Therapy Market Share by Region (2027–2032)
Table 10. NAD+ Intravenous Therapy Market Trends
Table 11. NAD+ Intravenous Therapy Market Drivers
Table 12. NAD+ Intravenous Therapy Market Challenges
Table 13. NAD+ Intravenous Therapy Market Restraints
Table 14. Global NAD+ Intravenous Therapy Revenue by Players (US$ Million), 2021–2026
Table 15. Global NAD+ Intravenous Therapy Market Share by Players (2021–2026)
Table 16. Global Top NAD+ Intravenous Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on NAD+ Intravenous Therapy Revenue, 2025
Table 17. Ranking of Global Top NAD+ Intravenous Therapy Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by NAD+ Intravenous Therapy Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of NAD+ Intravenous Therapy, Headquarters and Area Served
Table 20. Global Key Players of NAD+ Intravenous Therapy, Products and Applications
Table 21. Global Key Players of NAD+ Intravenous Therapy, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global NAD+ Intravenous Therapy Market Size by Type (US$ Million), 2021–2026
Table 24. Global NAD+ Intravenous Therapy Revenue Market Share by Type (2021–2026)
Table 25. Global NAD+ Intravenous Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global NAD+ Intravenous Therapy Revenue Market Share by Type (2027–2032)
Table 27. Global NAD+ Intravenous Therapy Market Size by Application (US$ Million), 2021–2026
Table 28. Global NAD+ Intravenous Therapy Revenue Market Share by Application (2021–2026)
Table 29. Global NAD+ Intravenous Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global NAD+ Intravenous Therapy Revenue Market Share by Application (2027–2032)
Table 31. North America NAD+ Intravenous Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America NAD+ Intravenous Therapy Market Size by Country (US$ Million), 2021–2026
Table 33. North America NAD+ Intravenous Therapy Market Size by Country (US$ Million), 2027–2032
Table 34. Europe NAD+ Intravenous Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe NAD+ Intravenous Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. Europe NAD+ Intravenous Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific NAD+ Intravenous Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific NAD+ Intravenous Therapy Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific NAD+ Intravenous Therapy Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America NAD+ Intravenous Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America NAD+ Intravenous Therapy Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America NAD+ Intravenous Therapy Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa NAD+ Intravenous Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa NAD+ Intravenous Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa NAD+ Intravenous Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. The Wellness Lab Company Details
Table 47. The Wellness Lab Business Overview
Table 48. The Wellness Lab NAD+ Intravenous Therapy Product
Table 49. The Wellness Lab Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 50. The Wellness Lab Recent Development
Table 51. Conciergemdla Company Details
Table 52. Conciergemdla Business Overview
Table 53. Conciergemdla NAD+ Intravenous Therapy Product
Table 54. Conciergemdla Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 55. Conciergemdla Recent Development
Table 56. Azivmedics Company Details
Table 57. Azivmedics Business Overview
Table 58. Azivmedics NAD+ Intravenous Therapy Product
Table 59. Azivmedics Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 60. Azivmedics Recent Development
Table 61. Reset IV Company Details
Table 62. Reset IV Business Overview
Table 63. Reset IV NAD+ Intravenous Therapy Product
Table 64. Reset IV Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 65. Reset IV Recent Development
Table 66. Thedripclub Company Details
Table 67. Thedripclub Business Overview
Table 68. Thedripclub NAD+ Intravenous Therapy Product
Table 69. Thedripclub Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 70. Thedripclub Recent Development
Table 71. Toronto Functional Medicine Centre Company Details
Table 72. Toronto Functional Medicine Centre Business Overview
Table 73. Toronto Functional Medicine Centre NAD+ Intravenous Therapy Product
Table 74. Toronto Functional Medicine Centre Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 75. Toronto Functional Medicine Centre Recent Development
Table 76. Mobileivmedics Company Details
Table 77. Mobileivmedics Business Overview
Table 78. Mobileivmedics NAD+ Intravenous Therapy Product
Table 79. Mobileivmedics Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 80. Mobileivmedics Recent Development
Table 81. Rocky Mountain Ivmedics Company Details
Table 82. Rocky Mountain Ivmedics Business Overview
Table 83. Rocky Mountain Ivmedics NAD+ Intravenous Therapy Product
Table 84. Rocky Mountain Ivmedics Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 85. Rocky Mountain Ivmedics Recent Development
Table 86. Seaside Skin Care Company Details
Table 87. Seaside Skin Care Business Overview
Table 88. Seaside Skin Care NAD+ Intravenous Therapy Product
Table 89. Seaside Skin Care Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 90. Seaside Skin Care Recent Development
Table 91. Premiumhealth Company Details
Table 92. Premiumhealth Business Overview
Table 93. Premiumhealth NAD+ Intravenous Therapy Product
Table 94. Premiumhealth Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 95. Premiumhealth Recent Development
Table 96. Effect Doctors Company Details
Table 97. Effect Doctors Business Overview
Table 98. Effect Doctors NAD+ Intravenous Therapy Product
Table 99. Effect Doctors Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 100. Effect Doctors Recent Development
Table 101. Nadclinic Company Details
Table 102. Nadclinic Business Overview
Table 103. Nadclinic NAD+ Intravenous Therapy Product
Table 104. Nadclinic Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 105. Nadclinic Recent Development
Table 106. Hydrate IV Bar Company Details
Table 107. Hydrate IV Bar Business Overview
Table 108. Hydrate IV Bar NAD+ Intravenous Therapy Product
Table 109. Hydrate IV Bar Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 110. Hydrate IV Bar Recent Development
Table 111. LIVV Natural Company Details
Table 112. LIVV Natural Business Overview
Table 113. LIVV Natural NAD+ Intravenous Therapy Product
Table 114. LIVV Natural Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 115. LIVV Natural Recent Development
Table 116. BioReset Medical Company Details
Table 117. BioReset Medical Business Overview
Table 118. BioReset Medical NAD+ Intravenous Therapy Product
Table 119. BioReset Medical Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 120. BioReset Medical Recent Development
Table 121. IV Boost UK Company Details
Table 122. IV Boost UK Business Overview
Table 123. IV Boost UK NAD+ Intravenous Therapy Product
Table 124. IV Boost UK Revenue in NAD+ Intravenous Therapy Business (US$ Million), 2021–2026
Table 125. IV Boost UK Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. NAD+ Intravenous Therapy Picture
Figure 2. Global NAD+ Intravenous Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global NAD+ Intravenous Therapy Market Share by Type: 2025 vs 2032
Figure 4. NAD+ Mixed Vitamin Injections Features
Figure 5. Pure NAD+ Injection Features
Figure 6. Global NAD+ Intravenous Therapy Market Size by Application (US$ Million), 2021–2032
Figure 7. Global NAD+ Intravenous Therapy Market Share by Application: 2025 vs 2032
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Residential Case Studies
Figure 11. NAD+ Intravenous Therapy Report Years Considered
Figure 12. Global NAD+ Intravenous Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global NAD+ Intravenous Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global NAD+ Intravenous Therapy Market Share by Region: 2025 vs 2032
Figure 15. Global NAD+ Intravenous Therapy Market Share by Players in 2025
Figure 16. Global NAD+ Intravenous Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by NAD+ Intravenous Therapy Revenue in 2025
Figure 18. North America NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America NAD+ Intravenous Therapy Market Share by Country (2021–2032)
Figure 20. United States NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe NAD+ Intravenous Therapy Market Share by Country (2021–2032)
Figure 24. Germany NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific NAD+ Intravenous Therapy Market Share by Region (2021–2032)
Figure 32. China NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America NAD+ Intravenous Therapy Market Share by Country (2021–2032)
Figure 40. Mexico NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa NAD+ Intravenous Therapy Market Share by Country (2021–2032)
Figure 44. Israel NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE NAD+ Intravenous Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. The Wellness Lab Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 48. Conciergemdla Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 49. Azivmedics Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 50. Reset IV Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 51. Thedripclub Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 52. Toronto Functional Medicine Centre Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 53. Mobileivmedics Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 54. Rocky Mountain Ivmedics Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 55. Seaside Skin Care Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 56. Premiumhealth Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 57. Effect Doctors Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 58. Nadclinic Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 59. Hydrate IV Bar Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 60. LIVV Natural Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 61. BioReset Medical Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 62. IV Boost UK Revenue Growth Rate in NAD+ Intravenous Therapy Business (2021–2026)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232